Navidea Biopharmaceuticals Inc Коэффициент "короткого" интереса
Что обозначает Коэффициент "короткого" интереса в Navidea Biopharmaceuticals Inc?
Коэффициент "короткого" интереса Navidea Biopharmaceuticals Inc является 1.45
Какое определение для Коэффициент "короткого" интереса?
Краткосрочный коэффициент - это количество проданных акций, которых нет в наличии, деленное на среднесуточный объем.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Коэффициент "короткого" интереса компаний в Health Care сектор на NYSEMKT по сравнению с Navidea Biopharmaceuticals Inc
Что делает Navidea Biopharmaceuticals Inc?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Компании с коэффициент "короткого" интереса похож на Navidea Biopharmaceuticals Inc
- Field Trip Health And Wellness имеет Коэффициент "короткого" интереса из 1.44
- Casper Sleep Inc имеет Коэффициент "короткого" интереса из 1.44
- Coca-Cola HBC AG имеет Коэффициент "короткого" интереса из 1.44
- U.S. Global Investors имеет Коэффициент "короткого" интереса из 1.44
- Alphabet Inc имеет Коэффициент "короткого" интереса из 1.44
- Apyx Medical имеет Коэффициент "короткого" интереса из 1.44
- Navidea Biopharmaceuticals Inc имеет Коэффициент "короткого" интереса из 1.45
- Forte Biosciences имеет Коэффициент "короткого" интереса из 1.46
- Fortune Brands Home & Security Inc имеет Коэффициент "короткого" интереса из 1.46
- Adial Pharmaceuticals имеет Коэффициент "короткого" интереса из 1.46
- Grupo Supervielle S.A имеет Коэффициент "короткого" интереса из 1.46
- Indiva имеет Коэффициент "короткого" интереса из 1.46
- Tribune Publishing имеет Коэффициент "короткого" интереса из 1.46